
Loading, please wait...

Loading, please wait...

Ketogenic diet therapy is established as a treatment option for drug-resistant epilepsy, but its role alongside long-term antiseizure medication remains clinically important. This 2024 cohort study evaluated adults and children with drug-resistant epilepsy who remained on ketogenic diet therapy for at least six months. More than half of participants were able to discontinue or reduce at least one antiseizure medication without requiring another antiseizure drug or restarting the original dose during follow-up. Among adults, the overall antiseizure medication load also fell. Importantly, the ability to reduce medication was not limited to patients with a major reduction in seizure frequency, suggesting that dietary therapy may sometimes facilitate medication simplification beyond its direct effect on seizures. The study is observational and does not establish that the diet itself caused medication reduction, so treatment decisions still require individual assessment. For HCPs, the practical value lies in thinking about ketogenic therapy as part of a broader treatment strategy rather than as a substitute for all conventional medication. Monitoring nutritional status, tolerability, adherence and seizure control remains essential. The findings are particularly relevant to paediatric and difficult-to-treat epilepsy programmes considering multimodal therapy.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Ketogenic diet therapy is established as a treatment option for drug-resistant epilepsy, but its role alongside long-term antiseizure medication remains clinically important. This 2024 cohort study evaluated adults and children with drug-resistant epilepsy who remained on ketogenic diet therapy for at least six months. More than half of participants were able to discontinue or reduce at least one antiseizure medication without requiring another antiseizure drug or restarting the original dose during follow-up. Among adults, the overall antiseizure medication load also fell. Importantly, the ability to reduce medication was not limited to patients with a major reduction in seizure frequency, suggesting that dietary therapy may sometimes facilitate medication simplification beyond its direct effect on seizures. The study is observational and does not establish that the diet itself caused medication reduction, so treatment decisions still require individual assessment. For HCPs, the practical value lies in thinking about ketogenic therapy as part of a broader treatment strategy rather than as a substitute for all conventional medication. Monitoring nutritional status, tolerability, adherence and seizure control remains essential. The findings are particularly relevant to paediatric and difficult-to-treat epilepsy programmes considering multimodal therapy.
4 weeks back

A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
3 days back

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back

Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
4 days back

A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back

Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back